Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Remigromig noninferior to ranibizumab in phase 2b/3 BRUNELLO DME trial
2
Retina Society 2026: AI flags retinal inflammation without dye
3
Nimesh Patel, MD, on low-dose atropine and SYD-101
4
Retina Society 2026: LUGANO secondary data show reduced treatment burden with vorolanib insert despite missed primary end point
5